Markets:

Overview

News

Currencies

International

Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.6700 +0.0046 (+0.69%)

Streaming Delayed Price Updated: 10:56 AM EDT, Apr 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Envoy Medical, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

April 01, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company...

Via Newsfile

Envoy Medical Reports Full Year 2025 Financial Results

March 23, 2026

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing...

Via Newsfile

Topics Intellectual Property

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

March 11, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - March 11, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

February 24, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

February 23, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

February 19, 2026

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor...

Via Newsfile

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

February 17, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - February 17, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

February 12, 2026

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full...

Via Newsfile

Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

February 11, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - February 11, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing

February 06, 2026

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th

February 02, 2026

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

January 29, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

December 18, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

December 16, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

December 10, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

December 04, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Announces the Grant of Its 40th U.S. Patent

December 02, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

November 20, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

November 18, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

November 10, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - November 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

November 04, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

October 29, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing

October 29, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical Receives Positive Listing Determination from NASDAQ

October 27, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

AI & Technology Virtual Investor Conference Agenda Announced for October 28th

October 23, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th

October 23, 2025

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

From Virtual Investor Conferences; Envoy Medical, Inc.

Via GlobeNewswire

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

October 09, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - October 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

Topics Regulatory Compliance

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

October 08, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

Via Newsfile

TOMI Environmental (NASDAQ: TOMZ) | Listeria in Packaged Meals – A Public Health Alert! More Stocks Inside

October 07, 2025

Via AB Newswire

Topics Death Lawsuit Product Recall

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

October 07, 2025

White Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"),...

Via Newsfile

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.